Generated banner for Digital Health Clinical Asr Build
Generated logo for Digital Health Clinical Asr Build

Digital Health Clinical Asr Build

NVIDIAOfficialCreated by Ben RandoingDistributed by NVIDIA

  • Skill
  • Workflow
  • Data and AI
  • Apache-2.0
  • Medium risk

From the author

Stage 2 of the Clinical ASR Flywheel. Use when curating clinical terms, tagging IPA, and synthesizing a NeMo manifest. NOT for scoring (use /digital-health-clinical-asr-eval).
— the description by Ben Randoing

AutoGineer summary

Written by AutoGineer from the skill’s own files, not by the author

This skill serves as the second stage of the Clinical ASR Flywheel, focusing on the creation of a benchmark dataset for clinical speech recognition. It guides users through a structured process of curating clinical terms, generating natural language sentences, and synthesizing audio using Magpie TTS. The process includes a two-tier IPA pipeline to ensure accurate pronunciation of medical terminology and results in a NeMo-format manifest ready for evaluation.

What it does

  • Curates clinical term lists across six specific categories: drug, procedure, anatomy, condition, lab, and role.
  • Generates natural language sentence variants for clinical terms using a designated designer tool.
  • Implements a two-tier IPA pipeline using pronunciation overrides and Merriam-Webster lookups.
  • Validates IPA candidates against the Magpie en-US phoneme inventory before synthesis.
  • Synthesizes audio clips using Magpie TTS with noise-injection and context-specific variants.
  • Produces a NeMo-format manifest with clinical extension fields for downstream evaluation.

When to use it

  • When you need to build a new clinical ASR benchmark or add terms to an existing one.
  • When you need to generate synthetic audio for medical terms to test ASR performance.
  • When you need to create a NeMo-format manifest for clinical speech evaluation.
  • When you need to audition and verify TTS pronunciations for complex clinical terminology.

Advantages

  • Provides a structured, repeatable methodology for building clinical ASR datasets.
  • Ensures pronunciation accuracy through a multi-tier IPA verification pipeline.
  • Supports cross-cycle consistency by using appendable pronunciation overrides.
  • Enables detailed performance breakdowns by tagging manifests with clinical metadata.

Usage examples

“Build a clinical ASR benchmark for oncology.”
The agent initiates the specialty interview, asks for relevant drug and procedure terms, and begins the curation process for the oncology domain.
“Add these cardiology terms to my existing benchmark.”
The agent guides you through the process of adding new terms to your current cycle, including IPA tagging and synthesis of only the new entries.

Install

  1. Download the skill as a ZIP:

    https://autogineer.com/agent-skills/nvidia/digital-health-clinical-asr-build/download
  2. Unzip it into the cross-client skills folder of your project:

    mkdir -p .agents/skills && unzip digital-health-clinical-asr-build.zip -d .agents/skills

Documentation by Ben Randoing

<!-- SPDX-FileCopyrightText: Copyright (c) 2026 NVIDIA CORPORATION & AFFILIATES. All rights reserved. SPDX-License-Identifier: Apache-2.0 -->

Clinical ASR Flywheel — Stage 2 (Build the benchmark)

⚠ Agent: read this entire SKILL.md before answering. This stage is conversational and gated. Specifically: ask the user 1–2 specialty-aware clarifying questions before proposing terms (Step 2a), walk them through the two-tier IPA pipeline (override → merriam-webster → magpie_g2p) in Step 2c, hit the explicit QA-mode audition gate in Step 2d before full Cartesian synthesis, and name KER as the headline metric they'll see in Stage 3. Skipping any of these defeats the methodology.

You are the curate-and-synthesize stage. The user arrives from /digital-health-clinical-asr-setup and leaves with a NeMo-format manifest.jsonl plus the audio it references — both ready for scoring at /digital-health-clinical-asr-eval.

Be conversational. This is the warmest, most domain-aware step in the flywheel: you're asking a clinician (or someone who works with them) which terms hurt today and shaping a benchmark around their reality. Ask short, focused questions. Show the user what's being added. Don't lecture.

Data leaves your environment — disclose this to the user before any term is sent

This stage transmits user-curated content to two external services. Surface this to the user before invoking either call:

ServiceWhat gets sentWhen
Merriam-Webster (dictionaryapi.com API or merriam-webster.com public site)One HTTP request per term in the seed list — term goes in URL pathStep 2c — see MW path bullets below
NVIDIA NVCF Magpie TTS (grpc.nvcf.nvidia.com)Each generated clinical sentence (text, plus any SSML IPA wrappers)Steps 2d and 2e, every synthesis call

Both endpoints expect non-PHI synthetic content — the term list you curate, the sentences /data-designer (or your fallback templates) generates from it. Do not pass real patient records, real ASR transcripts, or any PHI through this skill. If the term list itself is sensitive (proprietary drug codenames, unreleased product names, customer-confidential indications), confirm with the user that external-API transmission is acceptable under their organization's data-governance policy before proceeding.

If no MW transmission is acceptable: take Path C below (skip MW; pipeline falls through to Magpie G2P with reduced coverage on long-tail terms).

Purpose

Curate a clinical-specialty term list, generate eval audio for it through Magpie TTS with a two-tier IPA pipeline, and write a NeMo-format manifest tagged with the clinical-extension fields (term, entity_category, ipa_source, voice_id, noise_level, context_type). The output is the input to Stage 3.

By the end the user has:

$EVAL_DIR/cycle<N>/
├── audio/<slug>.wav        synthesized clips
├── manifest.jsonl          NeMo format + clinical extension
├── term_seed.csv           the curated input
└── pronunciation_overrides.csv   appendable across cycles

($EVAL_DIR is the user's own choice — this skill does not impose a layout. The structure above is a recommendation, not a requirement.)

When to use this skill

Activate on user phrases like:

  • "Build a clinical ASR benchmark"

  • "Curate drug names / procedure names for ASR eval"

  • "Generate eval audio for medical terms"

  • "Create a NeMo manifest from clinical terms"

  • "Add oncology / cardiology / ortho terms to my benchmark"

  • "Audition the TTS pronunciation for these drug names"

  • "Make me a cycle-N manifest"

Do not activate when (also: if the message mentions auth, API key, gRPC, streaming, riva-build, NIM deploy, NGC, or Docker, route per the bullets below and stop):

  • The user already has a manifest and wants to score it → /digital-health-clinical-asr-eval

  • The user wants to fine-tune on an existing manifest → /digital-health-clinical-asr-finetune

  • The user is asking generic TTS / SSML / voice-cloning / voice-catalog questions → /read-aloud (or /riva-tts)

  • TTS/ASR auth / API keys / gRPC / streaming → /riva-tts or /riva-asr

  • NIM deploy or riva-build / riva-deploy flags → /riva-asr-custom or /riva-tts-custom

  • NGC / Docker / NVIDIA Container Toolkit → /riva-nim-setup

  • The user is asking generic synthetic-data questions → /data-designer

Prerequisites

  • /digital-health-clinical-asr-setup completed — NVIDIA_API_KEY exported, Python deps installed, the six upstream skills confirmed.

  • /read-aloud (or /riva-tts) reachable. Hosted Magpie via NVCF is the default. Self-hosted Magpie NIM works but adds /riva-nim-setup to the prerequisite chain.

  • /data-designer reachable. Template fallback is acceptable for a first cycle if /data-designer is unavailable, but tag those rows so future cycles can re-generate.

  • A working directory the user owns. The skill recommends $EVAL_DIR/cycle<N>/ but does not enforce it.

Instructions

2a. Specialty interview → term_seed.csv

Ask one question at a time. The goal is to surface 4–10 candidate terms with the right entity_category, not to write a textbook.

Questions, in order:

  1. What specialty / workflow is this for? (oncology dictation, ICU handoff, psych intake, ortho post-op, …)

  2. What ASR failure modes have you seen? — drug names, multi-word procedures, abbreviations, compound conditions.

  3. Which terms come up daily vs which are the hard ones? — daily-common terms become the sanity baseline; daily-hard terms become the signal.

Propose 4–10 candidate terms with entity_category. Confirm with the user before writing. Then write term_seed.csv:

term,entity_category
cefazolin,drug
acetabular reamer,procedure
tibial plateau,anatomy
femoroacetabular impingement,condition
hemoglobin a1c,lab
respiratory therapist,role

The category vocabulary is fixed. KER keys off it. Allowed values:

drug | procedure | anatomy | condition | lab | role

If the user proposes a new category, push back: either it maps to one of the six, or the methodology needs a deliberate extension (which is a future cycle's job, not a one-off ad-hoc add).

2b. Sentence generation via /data-designer

Brief /data-designer with:

For each row in term_seed.csv, generate one or more natural English sentences embedding term in a way that fits the row's entity_category. Output schema: {term, entity_category, sentence, context_type}. Generate 3–5 context_type variants per term. Initial context_type vocabulary: dictation, handoff, chart_note, history. Sentence length 10–30 words.

The output of this step is a per-term sentence variants file. Any filename is fine — pick one and use it consistently across the cycle directory.

Template fallback. If /data-designer is unavailable, use a 4-template fallback (one per context_type) and substitute term mechanically. Tag those rows in the manifest (context_type is set, the sentence is just less natural) so a future cycle can regenerate.

2c. Two-tier IPA tagging (the load-bearing quality lever)

Every term passes through a 3-tier pipeline, in order:

  1. Override — pronunciation_overrides.csv carries verified IPA the team has audited. If term matches a row here, the override wins.

  2. Merriam-Webster — for un-overridden terms, fetch the MW respelling, convert to IPA, validate against Magpie's en-US phoneme set. If both succeed, the term is tagged merriam-webster.

  3. Magpie G2P (fall-through) — if neither override nor MW produces a valid IPA, the plain text is passed to Magpie's neural G2P at synthesis time. The row is tagged magpie_g2p.

Every manifest row carries the ipa_source tag (override | merriam-webster | magpie_g2p). The delta between merriam-webster and magpie_g2p rows in the Stage 3 leaderboard is the proof the pronunciation strategy is working — call it out explicitly when you produce the leaderboard.

Three MW lookup choices — all tag merriam-webster. A: dictionaryapi.com JSON API + DICTIONARY_API_KEY (free at dictionaryapi.com) — recommended for standalone use. B: HTML scrape of merriam-webster.com — no key, brittle to site HTML changes; recipe inlined in references/pronunciation-pipeline.md. C: skip MW, fall through to Magpie G2P with weaker long-tail coverage. Both recipes + the full respelling→IPA table live in references/pronunciation-pipeline.md. The Path A function takes api_key as an arg (never reads os.environ); pass None to skip MW.

pronunciation_overrides.csv schema:

term,ipa,verified_by,verified_at,notes
cefazolin,sɛfəˈzoʊlɪn,brandoing,2026-05-13,confirmed against MW respelling + ear test

Append-only across cycles. Re-running the build later picks up new entries automatically.

2d. QA-mode synthesis (do not skip this gate)

Before running the full Cartesian product, synthesize one wav per term with: first voice, clean noise, default context. Audition each clip with the user.

For every term tagged magpie_g2p, propose an IPA candidate using clinical suffix patterns and validate against Magpie's en-US phoneme set before suggesting:

SuffixStress pattern (example)
-mycin…ˈmaɪsɪn (vancomycin, gentamicin)
-prazole…ˈpreɪzoʊl (esomeprazole, omeprazole)
-statin…ˈstætɪn (atorvastatin, rosuvastatin)
-sartan…ˈsɑːrtən (losartan, valsartan)
-azole…ˈeɪzoʊl (fluconazole, ketoconazole)
-cillin…ˈsɪlɪn (amoxicillin, piperacillin)
-parin…ˈpɛərɪn (enoxaparin, heparin)

Phoneme-validation pattern — live-probe Magpie's en-US neural G2P with a candidate IPA. If Magpie accepts the SSML, the IPA is in its inventory. Use the suffix patterns above as a pre-filter (cheap heuristic) and the live probe to confirm before committing to an override. The magpie_validates_ipa(ipa, api_key, voice_id) recipe — a minimal NVCF gRPC synthesis call that returns True/False fail-closed — is in references/pronunciation-pipeline.md.

Call it once per candidate IPA before showing it to the user. On user approval, append the verified IPA to pronunciation_overrides.csv. The row's ipa_source flips from magpie_g2p to override on the next manifest generation.

HITL audition gate before Step 2e — fail-closed. Do not synthesize the full Cartesian product, do not promote any staged IPA candidate to pronunciation_overrides.csv, and do not advance to Stage 3 until one of the following has happened explicitly in conversation:

  1. The user confirms they have auditioned the QA clips and reports their verdict per clip (or per bucket: "the MW set sounds fine", "fix pembrolizumab", etc.). Provide the afplay (macOS) or paplay/aplay (Linux) commands so the user can play them — then halt and wait for their reply after listening. Paper-only approval via an AskUserQuestion prompt — clicking "Promote all" or "Lock in" without auditioning — does not satisfy this gate. Magpie-validating an IPA proves it's in the phoneme inventory; it does not prove it matches the intended pronunciation. Only the user's ears do that.

  2. The user explicitly opts to skip audition for this cycle, in deliberate language (e.g. "skip audition, accept the risk that mispronunciations may dilute the Stage 3 KER signal — log it as a cycle-N caveat"), not as a side-effect of a single click-through. Record the skip in a cycle-level note (e.g. eval/cycle<N>/cycle_notes.md) so a future operator can see the audition was deferred.

Magpie NVCF rate-limits aggressively on >100-row jobs, and a do-over costs both API credits and clock time — but the larger risk is shipping a manifest with mispronounced reference audio that quietly corrupts the Stage 3 KER signal. Time spent auditioning is cheaper than re-running the cycle.

2e. Full benchmark generation

After pronunciations are locked, generate the full Cartesian product |terms| × |voices| × |noise_levels| × |context_types|. Defaults: 2–4 Magpie en-US voices (Mia/Jason/Ray), [clean, snr_15db, snr_5db], [dictation, handoff, chart_note, history].

Self-contained synthesis — no /read-aloud required. The synthesize_row(row, all_overrides, out_dir, api_key) recipe — opens an NVCF gRPC stream, wraps overrides into SSML via render_sentence_with_overrides, writes 16-bit mono PCM to <out_dir>/audio/<slug>.wav — is in references/pronunciation-pipeline.md (§Synthesis call). Key invariant: all_overrides carries every entry from pronunciation_overrides.csv (including context-word overrides like intravenously) so the renderer wraps any override whose verbatim text appears in row['text']. Wrapping only row['term'] silently drops context-word overrides.

Noise-injection (clean → snr_15db → snr_5db) and the manifest schema (NeMo canonical fields + clinical extension, plus pre-flight schema and audio-existence checks) all live in references/manifest-schema.md.

Warn when product > 100 rows. Magpie NVCF rate-limits with ~5–10% RESOURCE_EXHAUSTED drops on big runs. Re-run the dropped rows.

Stage 2 completion checklist

Don't consider Stage 2 done until all five sub-steps ran. Agents commonly stop after 2a or 2b; the goal is a synthesized manifest plus a hand-off:

  • 2a — term_seed.csv, 4–10 terms, entity_category ∈ {drug, procedure, anatomy, condition, lab, role}

  • 2b — 3–5 context_type sentence variants per term

  • 2c — every term tagged ipa_source ∈ {override, merriam-webster, magpie_g2p}

  • 2d — QA wavs auditioned, IPA overrides locked with explicit user approval

  • 2e — manifest.jsonl + per-row audio for the Cartesian product

  • Hand-off — name /digital-health-clinical-asr-eval as the next skill and KER as its headline metric

Writes go only into the user-chosen $EVAL_DIR/cycle<N>/. Don't write elsewhere, modify env, or install packages — those belong to /digital-health-clinical-asr-setup.

Examples

Scenario A — fresh oncology benchmark. User: "We're seeing chemo drug names mistranscribed. Where do I start?" → Step 2a: confirm specialty is oncology, ask about which drugs (immunotherapy biologics, platinum agents, taxanes). Propose ~10 candidates: cisplatin, paclitaxel, pembrolizumab, nivolumab, carboplatin, docetaxel, bevacizumab, trastuzumab, cetuximab, pemetrexed. Write term_seed.csv with all entity_category=drug. Step 2b: brief /data-designer for 4 context variants each = 40 sentences. Step 2c: MW lookup for each — biologics like pembrolizumab will likely fall to magpie_g2p; platinum agents likely hit MW. Step 2d: synthesize one QA wav per term, walk the user through the pembrolizumab etc. clips, propose IPA candidates with -mab suffix stress patterns. Step 2e: on approval, run 10 terms × 2 voices × 2 noise levels × 3 contexts = 120 rows.

Scenario B — appending to an existing cycle. User: "I have a cycle-1 manifest and I want to add 5 more procedures." → Re-run only Steps 2a (specialty interview just for the new terms), 2b (sentence gen for the additions), 2c (IPA pipeline for the additions), 2d (audition the new terms), and 2e (synthesize only the new term rows). Append to the existing manifest.jsonl. Do not regenerate audio for existing terms — cycle isolation is intentional so leaderboards diff cycle N vs cycle N+1 cleanly.

Artifacts produced

  • term_seed.csv — curated terms with entity_category

  • pronunciation_overrides.csv — verified IPA, appendable across cycles

  • manifest.jsonl — NeMo format with clinical extension fields (one JSON object per line)

  • audio/<slug>.wav — synthesized clips, one per manifest row

Troubleshooting

  • TTS rate-limit drops (RESOURCE_EXHAUSTED) on >100-row generation → expected on Magpie NVCF. Confirm exponential backoff is active in /read-aloud; expect ~5–10% drops on big runs and re-run for the gaps.

  • All ipa_source rows tagged magpie_g2p → MW lookup is failing across the board, or candidate IPAs are failing phoneme validation. Re-verify whichever MW path you configured (DICTIONARY_API_KEY for A; HTTPS reachability + parser for B), then check candidates against Magpie's en-US phoneme inventory.

  • Magpie mispronounces a term even with the IPA override → first verify the IPA is in the Magpie en-US phoneme inventory and the SSML wrapping is syntactically valid. If both check out, the underlying TTS bug is owned by /read-aloud (/riva-tts) — route there for diagnosis. This skill provides the override mechanism but does not own the neural G2P or SSML parser.

  • Sentence variants from /data-designer are bland / template-like → check the brief; the schema-only prompt sometimes produces stereotyped output. Add 1–2 in-context examples to the brief and re-run.

  • Audio files exist but manifest.jsonl is short → manifest writer skipped rows whose synthesis returned a NVCF error. Re-run the build with only the missing rows.

For anything not in this list, identify which upstream skill is implicated and route there. The digital-health-clinical-asr-build skill owns the methodology, not the TTS or DataDesigner internals.

Limitations

  • English-only by default. Magpie's en-US phoneme inventory is what the two-tier IPA pipeline validates against. Other locales need a different upstream phoneme set + override CSV format.

  • Six fixed entity categories. Extending entity_category is a deliberate methodology change, not a one-off tweak — KER breakdowns, leaderboard sections, and downstream finetune scripts all key off the vocabulary.

  • Tiny first cycles. Below ~20 terms, the by-ipa_source leaderboard split won't have enough rows in each bucket to be statistically meaningful. Build a meaningful cycle even if it costs a session.

  • Magpie NVCF rate-limits. ~5–10% drops on large jobs; budget a re-run pass.

Next steps

  • Forward: /digital-health-clinical-asr-eval — transcribe the manifest, score WER/CER/KER/SER, produce the five-section leaderboard.

  • Back to setup (if anything in the env is broken): /digital-health-clinical-asr-setup.

  • Lateral for TTS-specific debugging: /read-aloud or /riva-tts.

References

  • references/manifest-schema.md — NeMo canonical fields + clinical extension; pre-flight schema and audio-existence checks; cross-cycle stability rules

Files

LICENSE

Copyright (c) 2026 NVIDIA CORPORATION & AFFILIATES. All rights reserved.


                                 Apache License
                           Version 2.0, January 2004
                        http://www.apache.org/licenses/

   TERMS AND CONDITIONS FOR USE, REPRODUCTION, AND DISTRIBUTION

   1. Definitions.

      "License" shall mean the terms and conditions for use, reproduction,
      and distribution as defined by Sections 1 through 9 of this document.

      "Licensor" shall mean the copyright owner or entity authorized by
      the copyright owner that is granting the License.

      "Legal Entity" shall mean the union of the acting entity and all
      other entities that control, are controlled by, or are under common
      control with that entity. For the purposes of this definition,
      "control" means (i) the power, direct or indirect, to cause the
      direction or management of such entity, whether by contract or
      otherwise, or (ii) ownership of fifty percent (50%) or more of the
      outstanding shares, or (iii) beneficial ownership of such entity.

      "You" (or "Your") shall mean an individual or Legal Entity
      exercising permissions granted by this License.

      "Source" form shall mean the preferred form for making modifications,
      including but not limited to software source code, documentation
      source, and configuration files.

      "Object" form shall mean any form resulting from mechanical
      transformation or translation of a Source form, including but
      not limited to compiled object code, generated documentation,
      and conversions to other media types.

      "Work" shall mean the work of authorship, whether in Source or
      Object form, made available under the License, as indicated by a
      copyright notice that is included in or attached to the work
      (an example is provided in the Appendix below).

      "Derivative Works" shall mean any work, whether in Source or Object
      form, that is based on (or derived from) the Work and for which the
      editorial revisions, annotations, elaborations, or other modifications
      represent, as a whole, an original work of authorship. For the purposes
      of this License, Derivative Works shall not include works that remain
      separable from, or merely link (or bind by name) to the interfaces of,
      the Work and Derivative Works thereof.

      "Contribution" shall mean any work of authorship, including
      the original version of the Work and any modifications or additions
      to that Work or Derivative Works thereof, that is intentionally
      submitted to Licensor for inclusion in the Work by the copyright owner
      or by an individual or Legal Entity authorized to submit on behalf of
      the copyright owner. For the purposes of this definition, "submitted"
      means any form of electronic, verbal, or written communication sent
      to the Licensor or its representatives, including but not limited to
      communication on electronic mailing lists, source code control systems,
      and issue tracking systems that are managed by, or on behalf of, the
      Licensor for the purpose of discussing and improving the Work, but
      excluding communication that is conspicuously marked or otherwise
      designated in writing by the copyright owner as "Not a Contribution."

      "Contributor" shall mean Licensor and any individual or Legal Entity
      on behalf of whom a Contribution has been received by Licensor and
      subsequently incorporated within the Work.

   2. Grant of Copyright License. Subject to the terms and conditions of
      this License, each Contributor hereby grants to You a perpetual,
      worldwide, non-exclusive, no-charge, royalty-free, irrevocable
      copyright license to reproduce, prepare Derivative Works of,
      publicly display, publicly perform, sublicense, and distribute the
      Work and such Derivative Works in Source or Object form.

   3. Grant of Patent License. Subject to the terms and conditions of
      this License, each Contributor hereby grants to You a perpetual,
      worldwide, non-exclusive, no-charge, royalty-free, irrevocable
      (except as stated in this section) patent license to make, have made,
      use, offer to sell, sell, import, and otherwise transfer the Work,
      where such license applies only to those patent claims licensable
      by such Contributor that are necessarily infringed by their
      Contribution(s) alone or by combination of their Contribution(s)
      with the Work to which such Contribution(s) was submitted. If You
      institute patent litigation against any entity (including a
      cross-claim or counterclaim in a lawsuit) alleging that the Work
      or a Contribution incorporated within the Work constitutes direct
      or contributory patent infringement, then any patent licenses
      granted to You under this License for that Work shall terminate
      as of the date such litigation is filed.

   4. Redistribution. You may reproduce and distribute copies of the
      Work or Derivative Works thereof in any medium, with or without
      modifications, and in Source or Object form, provided that You
      meet the following conditions:

      (a) You must give any other recipients of the Work or
          Derivative Works a copy of this License; and

      (b) You must cause any modified files to carry prominent notices
          stating that You changed the files; and

      (c) You must retain, in the Source form of any Derivative Works
          that You distribute, all copyright, patent, trademark, and
          attribution notices from the Source form of the Work,
          excluding those notices that do not pertain to any part of
          the Derivative Works; and

      (d) If the Work includes a "NOTICE" text file as part of its
          distribution, then any Derivative Works that You distribute must
          include a readable copy of the attribution notices contained
          within such NOTICE file, excluding those notices that do not
          pertain to any part of the Derivative Works, in at least one
          of the following places: within a NOTICE text file distributed
          as part of the Derivative Works; within the Source form or
          documentation, if provided along with the Derivative Works; or,
          within a display generated by the Derivative Works, if and
          wherever such third-party notices normally appear. The contents
          of the NOTICE file are for informational purposes only and
          do not modify the License. You may add Your own attribution
          notices within Derivative Works that You distribute, alongside
          or as an addendum to the NOTICE text from the Work, provided
          that such additional attribution notices cannot be construed
          as modifying the License.

      You may add Your own copyright statement to Your modifications and
      may provide additional or different license terms and conditions
      for use, reproduction, or distribution of Your modifications, or
      for any such Derivative Works as a whole, provided Your use,
      reproduction, and distribution of the Work otherwise complies with
      the conditions stated in this License.

   5. Submission of Contributions. Unless You explicitly state otherwise,
      any Contribution intentionally submitted for inclusion in the Work
      by You to the Licensor shall be under the terms and conditions of
      this License, without any additional terms or conditions.
      Notwithstanding the above, nothing herein shall supersede or modify
      the terms of any separate license agreement you may have executed
      with Licensor regarding such Contributions.

   6. Trademarks. This License does not grant permission to use the trade
      names, trademarks, service marks, or product names of the Licensor,
      except as required for reasonable and customary use in describing the
      origin of the Work and reproducing the content of the NOTICE file.

   7. Disclaimer of Warranty. Unless required by applicable law or
      agreed to in writing, Licensor provides the Work (and each
      Contributor provides its Contributions) on an "AS IS" BASIS,
      WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or
      implied, including, without limitation, any warranties or conditions
      of TITLE, NON-INFRINGEMENT, MERCHANTABILITY, or FITNESS FOR A
      PARTICULAR PURPOSE. You are solely responsible for determining the
      appropriateness of using or redistributing the Work and assume any
      risks associated with Your exercise of permissions under this License.

   8. Limitation of Liability. In no event and under no legal theory,
      whether in tort (including negligence), contract, or otherwise,
      unless required by applicable law (such as deliberate and grossly
      negligent acts) or agreed to in writing, shall any Contributor be
      liable to You for damages, including any direct, indirect, special,
      incidental, or consequential damages of any character arising as a
      result of this License or out of the use or inability to use the
      Work (including but not limited to damages for loss of goodwill,
      work stoppage, computer failure or malfunction, or any and all
      other commercial damages or losses), even if such Contributor
      has been advised of the possibility of such damages.

   9. Accepting Warranty or Additional Liability. While redistributing
      the Work or Derivative Works thereof, You may choose to offer,
      and charge a fee for, acceptance of support, warranty, indemnity,
      or other liability obligations and/or rights consistent with this
      License. However, in accepting such obligations, You may act only
      on Your own behalf and on Your sole responsibility, not on behalf
      of any other Contributor, and only if You agree to indemnify,
      defend, and hold each Contributor harmless for any liability
      incurred by, or claims asserted against, such Contributor by reason
      of your accepting any such warranty or additional liability.

   END OF TERMS AND CONDITIONS

   APPENDIX: How to apply the Apache License to your work.

      To apply the Apache License to your work, attach the following
      boilerplate notice, with the fields enclosed by brackets "[]"
      replaced with your own identifying information. (Don't include
      the brackets!)  The text should be enclosed in the appropriate
      comment syntax for the file format. We also recommend that a
      file or class name and description of purpose be included on the
      same "printed page" as the copyright notice for easier
      identification within third-party archives.

   Copyright [yyyy] [name of copyright owner]

   Licensed under the Apache License, Version 2.0 (the "License");
   you may not use this file except in compliance with the License.
   You may obtain a copy of the License at

       http://www.apache.org/licenses/LICENSE-2.0

   Unless required by applicable law or agreed to in writing, software
   distributed under the License is distributed on an "AS IS" BASIS,
   WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.
   See the License for the specific language governing permissions and
   limitations under the License.

Requirements and compatibility

Written for: Claude Code

Works with: Claude Code, Claude apps, OpenAI Codex, GitHub Copilot, Cursor, Gemini CLI, Kiro, OpenCode, Goose, Amp, Roo Code, JetBrains Junie, Factory Droid, Devin (ex-Windsurf), Mistral Vibe, OpenHands, Letta

“Works with” means the tool reads the open Agent Skills format; a skill written for one tool may use features others lack.

Needs: Names Claude Code tools, Needs an API key

The author says: NVIDIA_API_KEY (required) for hosted Magpie TTS via NVCF. DICTIONARY_API_KEY (optional) for Merriam-Webster Medical Dictionary lookup. Stage 1 (/digital-health-clinical-asr-setup) must have been completed first. All TTS, IPA, and synthesis recipes are inlined — no sibling agent skill required.

Security

What our scanner noticed· Medium risk

  • Large base64-encoded blobs
  • Instructions that use the network

A static scan is not a guarantee. Skills are third-party content: review a skill before you let an agent use it.

Attribution and licence

Created by
Ben Randoing
Publisher
NVIDIA (Official)
Distributed by
NVIDIA
Source
NVIDIA/skills · skills/digital-health-clinical-asr-build · commit fce3cca
Licence
Apache License 2.0 (redistribution allowed)
  • LICENSE (added by AutoGineer from LICENSE-APACHE)
  • ATTRIBUTION.md (written by AutoGineer)
Synced

AutoGineer is not affiliated with or endorsed by Ben Randoing or NVIDIA.

Download ZIP

The ZIP holds the skill’s files, its licence files and an ATTRIBUTION.md. Download digital-health-clinical-asr-build.zip